To examine this possibility, we expressed two CRISPR gRNAs in MOLT-4 cells, a T lymphoblast cell line derived from an acute lymphoblastic leukemia (T-ALL) patient, which constitutively expresses PD-1. The gene discussed is PDCD1; the disease is acute lymphoblastic leukemia.